KAUPINEN WES enters PALVELLA THERAPEUTICS, INC. with 1.61M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/16/2024ACC: 0001062993-24-020697
DirectorOfficer10% Owner· President and CEO
Since Feb 2026
1.61M
Baseline shares
3% direct
42.94K
Direct ownership
1 position
102.89K
Derivative underlying
2 instruments
3
Security positions
1.56M indirect
Non-Derivative Holdings3
Common Stock
DirectShares owned42.94K
Common Stock
IndirectShares owned781.41K
Common Stock
IndirectShares owned781.41K
Total
42.94K direct·1.56M indirect1.61M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 42.94K | Direct |
| Common Stock | 781.41K | Indirect |
| Common Stock | 781.41K | Indirect |
| Total | 1.61M | 42.94K direct·1.56M indirect |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
81.46K
Shares owned
N/A
Exercise price
7.53
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
21.43K
Shares owned
N/A
Exercise price
9.79
Expiration
—
Exercise window
—
Total
Underlying
102.89K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 7.53 | — | — | 81.46K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 9.79 | — | — | 21.43K | N/A |
| Total | 102.89K | 0.00 | ||||